Lipid nanoparticles for oral delivery of nucleic acids for treating inflammatory bowel disease
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Nanomedicine (London, England) - 17(2022), 21 vom: 18. Sept., Seite 1501-1504 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yang, Chunhua [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 23.01.2023 Date Revised 15.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/nnm-2022-0222 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348316429 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348316429 | ||
| 003 | DE-627 | ||
| 005 | 20231226035904.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/nnm-2022-0222 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1161.xml |
| 035 | |a (DE-627)NLM348316429 | ||
| 035 | |a (NLM)36317587 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yang, Chunhua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lipid nanoparticles for oral delivery of nucleic acids for treating inflammatory bowel disease |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.01.2023 | ||
| 500 | |a Date Revised 15.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a Crohn's disease | |
| 650 | 4 | |a gene therapy | |
| 650 | 4 | |a plant-derived lipid nanoparticles | |
| 650 | 4 | |a solid lipid nanoparticles | |
| 650 | 4 | |a targeted drug delivery | |
| 650 | 4 | |a ulcerative colitis | |
| 650 | 7 | |a Lipid Nanoparticles |2 NLM | |
| 650 | 7 | |a Nucleic Acids |2 NLM | |
| 700 | 1 | |a Alpini, Gianfranco |e verfasserin |4 aut | |
| 700 | 1 | |a Glaser, Shannon |e verfasserin |4 aut | |
| 700 | 1 | |a Merlin, Didier |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nanomedicine (London, England) |d 2006 |g 17(2022), 21 vom: 18. Sept., Seite 1501-1504 |w (DE-627)NLM17228452X |x 1748-6963 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2022 |g number:21 |g day:18 |g month:09 |g pages:1501-1504 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/nnm-2022-0222 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2022 |e 21 |b 18 |c 09 |h 1501-1504 | ||